Amanote Research
Register
Sign In
Effect of Bilastine on Chronic Spontaneous Urticaria Refractory to Other Antihistamines
Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12053
Full Text
Open PDF
Abstract
Available in
full text
Date
March 5, 2019
Authors
Shigeki Inui
Publisher
Wiley
Related search
Treatment Refractory Chronic Spontaneous Urticaria Patients Achieves Remission With Low Molecular Weight Heparin
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab Updosing Allows Disease Activity Control in Refractory Patients With Chronic Spontaneous Urticaria
British Journal of Dermatology
Dermatology
Medicine
Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
Frontiers in Immunology
Allergy
Immunology
Efficacy and Safety of Methotrexate Add-On Therapy Versus Placebo for Patients With Chronic Spontaneous Urticaria Resistant to H1-Antihistamines: A Randomized, Controlled Trial
Journal of the American Academy of Dermatology
Dermatology
Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Efficacy of Switching to Bilastine, a Histamine H1 Receptor Antagonist, in Patients With Chronic Spontaneous Urticaria (H1-Switch): Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria
Bőrgyógyászati és Venerológiai Szemle
Cost of Treatment of Chronic Spontaneous Urticaria in Turkey
Health
